Skip to main content

Table 1 Clinical details of reviewed pediatric cases with Actinobaculum schaalii infection

From: Actinobaculum schaalii an emerging pediatric pathogen?

Age (years) Sex Clinical presentation Specimen withA. schaalii Concomitant flora Underlying urogenital tract pathologies Other underlying risk factors Antibiotic treatment Duration of treatment(days) Outcome Reference
0.66 m cystitis urine none neurogenic bladder myelomeningocele diaper co-trimoxazole followed by amoxicillin 7 14 recovery our case
0.75 f cauda equina syndrome pus from intradural abscess non-hemolytic streptococci none syringomyelia diaper penicillin, metronidazol not specified recovery 10
3 f cystitis urine Klebsiella pneumoniae none recurrent UTI diaper trimethoprim followed by amoxicillin 7 10 recovery 21
5 m pyelonephritis urine none pyeloureteral junction obstruction inborn right hemispheric tissue lesions with left-sided hemiplegia epilepsy amoxicillin/clavulanic acid followed by vancomycin 2 14 recovery 4
13 m cystitis urine none neurogenic bladder enuresis pivampicillin followed by mecillinam followed by pivampicillin 20 10 14 re-infection after 1 year recovery 21
15 m cystitis urine none neurogenic bladder vesicoureteral reflux bladder diverticulum myelomeningocele paraplegia amoxicillin/clavulanic acid 7 recovery *
  1. *Personal communication, Reto Lienhard, Department of Microbiology, La Chaux-de-Fonds.